Browsing Tag

Mergers & Acquisitions

420 posts

Merck & Co. Completes Spin-off of Organon
By

By
Merck & Co. has completed the spin-off of its women’s health, legacy brands, and biosimilars businesses, into a new separate company, Organon & Co. Merck announced the spin-off last year…

Global Pharma Briefs: News from Novo Nordisk, Biogen, and Bayer
By

By
A roundup of news from Denmark (Novo Nordisk, Heartseed), Switzerland (Biogen), and the US (Bayer, The Discovery Labs, University of Pennsylvania). Denmark Novo Nordisk, Heartseed in $598-M Pact for Stem-Cell…

Global Pharma Briefs: News from J&J, BMS, AbbVie and Bayer
By

By
A roundup of news from Africa (J&J), Germany (Bayer, BioNTech), India (BMS, Syngene), Poland (Moderna), the UK (Clarivate) and the US (Biogen, AbbVie, others). Africa J&J Supplies WHO with Vaccine…

Roivant Sciences in SPAC Deal Valuing the Company at $7.3 Bn
By

By
Roivant Sciences, a New York-based bio/pharmaceutical and healthcare technology company, and Montes Archimedes Acquisition Corp. (MAAC), a special purpose acquisition company (SPAC) sponsored by Patient Square Capital, have formed a…

Pfizer Acquires Amplyx Pharmaceuticals
By

By
Pfizer has acquired Amplyx Pharmaceuticals, a San Diego, California-based biopharmaceutical company developing therapies for people with compromised immune systems susceptible to fungal infections. Financial terms were not disclosed. Amplyx’s lead…

Amgen Completes $1.9-Bn Acquisition of Five Prime Therapeutics
By

By
Amgen has completed its previously announced acquisition of Five Prime Therapeutics, a South San Francisco, California-based company developing immuno-oncology and targeted cancer therapies, for approximately $1.9 billion. Amgen had announced…

Sanofi Acquires Kymab in $1.45-Bn Deal and Tidal in $470-M Deal
By

By
Sanofi has completed two acquisitions: Kymab, a Cambridge, UK-based biopharmaceutical company, in a $1.45-billion deal ($1.1 billion upfront and up to $350 million in milestones) and Tidal Therapeutics, a Cambridge,…

Global Pharma Briefs: News from Merck & Co., Sanofi, Bausch Health
By

By
A roundup of news from Egypt (Bausch Health), Japan (Daiichi Sankyo, Sanofi), UK (AstraZeneca), and the US (Merck & Co., Sandoz, Zydus, Alembic, and Apotex). Egypt Bausch Health To Sell…

Merck & Co. Completes $1.85-Bn Acquisition of Pandion Therapeutics
By

By
Merck & Co. has completed its $1.85-billion acquisition of Pandion Therapeutics, a Watertown, Massachusetts-based company developing bispecific antibody therapeutics for autoimmune diseases. It also has separately agreed to acquire Alydia…

Servier Acquires Agios’ Oncology Business for $2 Bn
By

By
Servier, a Paris-based pharmaceutical company, has acquired the commercial, clinical, and research-stage oncology portfolio of Agios Pharmaceuticals, a Cambridge, Massachusetts-based pharmaceutical company, for up to $2 billion plus royalties. Agios…